BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37013782)

  • 1. Oxaliplatin-induced hypersensitivity reactions: risk factors and management.
    Selcuk A; Yıldız B
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(6):2640-2645. PubMed ID: 37013782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol.
    Okayama T; Ishikawa T; Sugatani K; Yoshida N; Kokura S; Matsuda K; Tsukamoto S; Ihara N; Kuriu Y; Nakanishi M; Nakamura T; Kamada K; Katada K; Uchiyama K; Takagi T; Handa O; Konishi H; Yagi N; Naito Y; Otsuji E; Hosoi H; Miki T; Itoh Y
    Clin Ther; 2015 Jun; 37(6):1259-69. PubMed ID: 25862137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
    Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
    Clin Colorectal Cancer; 2009 Apr; 8(2):106-9. PubMed ID: 19739272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin: Detection and Management of Hypersensitivity Reactions.
    Rogers BB; Cuddahy T; Briscella C; Ross N; Olszanski AJ; Denlinger CS
    Clin J Oncol Nurs; 2019 Feb; 23(1):68-75. PubMed ID: 30682002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity.
    Alonso Martinez S; Segal NH; Cercek A; Yaeger R; Stadler Z; Kemeny NE; Nusrat M; Shahrokni A; Connell L; Saltz LB
    Clin Colorectal Cancer; 2022 Jun; 21(2):149-153. PubMed ID: 35125319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features of Oxaliplatin-induced Hypersensitivity Reactions in Chinese Patients: A Retrospective Multicenter Analysis.
    Li M; Jiang C; Yang JW; Yu ZQ; Li W; Zhao L; Song QY; Zhang CL; Liu D
    Curr Med Sci; 2021 Aug; 41(4):827-831. PubMed ID: 34403109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
    Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
    Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
    Wang AL; Patil SU; Long AA; Banerji A
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.
    Takase N; Matsumoto K; Onoe T; Kitao A; Tanioka M; Kikukawa Y; Yamaguchi S; Fujiwara K; Negoro S
    Int J Clin Oncol; 2015 Jun; 20(3):566-73. PubMed ID: 25030546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM; Lee CW; Matulonis UA; Castells M
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer.
    Altwerger G; Florsheim EB; Menderes G; Black J; Schwab C; Gressel GM; Nelson WK; Carusillo N; Passante T; Huang G; Litkouhi B; Azodi M; Silasi DA; Santin A; Schwartz PE; Ratner ES
    J Cancer Res Clin Oncol; 2018 Dec; 144(12):2449-2456. PubMed ID: 30255380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Incidence and Management of Hypersensitivity and Infusion Reactions in an Outpatient Chemotherapy Center].
    Sekine H; Akaiwa A; Onozawa Y; Kinjo T; Nakamura H; Nakamura R; Nawa M; Yoshida S; Araki N; Iizuka M; Shimizu H; Sunaga N; Tsukamoto N
    Gan To Kagaku Ryoho; 2018 Nov; 45(11):1625-1629. PubMed ID: 30449851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early Detection of and Initial Response to Oxaliplatin-Related Hypersensitivity Reactions].
    Taniguchi J; Itonaga S; Kanazawa E; Murakami M; Saeki A; Hashimoto M
    Gan To Kagaku Ryoho; 2020 Jan; 47(1):61-65. PubMed ID: 32381864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of a Undiluted, One-Bag Desensitization Protocol for Chemotherapeutic Agents.
    Iglesias-Santamaría A; Castellano Copa P
    Ann Pharmacother; 2023 Jan; 57(1):55-61. PubMed ID: 35570798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Rapid Drug Desensitization to Chemotherapy Affect Survival Outcomes?
    Berges-Gimeno MP; Carpio-Escalona LV; Longo-Muñoz F; Bernal-Rubio L; Lopez-Gonzalez P; Gehlhaar P; Pachon V; Ferreiro-Monteagudo R; Madrigal-Burgaleta R; Alvarez-Cuesta E
    J Investig Allergol Clin Immunol; 2020; 30(4):254-263. PubMed ID: 31188129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol.
    Syrigou EI; Karapanagiotou EM; Alamara CV; Boura PG; Saif MW; Syrigos KN
    Clin Colorectal Cancer; 2009 Mar; 8(2):106-9. PubMed ID: 19423504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.
    Picard M; Castells MC
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):177-91. PubMed ID: 24740483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin hypersensitivity: evaluation, implications of skin testing, and desensitization.
    Wong JT; Ling M; Patil S; Banerji A; Long A
    J Allergy Clin Immunol Pract; 2014; 2(1):40-5. PubMed ID: 24565767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.